Stay updated on Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial
Sign up to get notified when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.

Latest updates to the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows Revision: v3.3.2, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedThe notice about lapse in government funding and the related operating-status links have been removed from the page. As a result, users may not see warnings about information freshness or where to check current operating status.SummaryDifference0.3%

- Check35 days agoChange DetectedObserved minor formatting changes on the study page and an updated last-updated timestamp. There are no changes to core study data such as eligibility, endpoints, enrollment, or locations.SummaryDifference0.4%

- Check63 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

- Check71 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check85 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2 and removed the Back to Top element. No substantive changes to core content, pricing, stock, or other critical information.SummaryDifference0.1%

Stay in the know with updates to Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.